Susan J Zieman

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension
    Susan J Zieman
    Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Hypertens 25:577-83. 2007
  2. ncbi Mechanisms, pathophysiology, and therapy of arterial stiffness
    Susan J Zieman
    Department of Medicine, Cardiology Division, National Institute on Aging, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Arterioscler Thromb Vasc Biol 25:932-43. 2005
  3. ncbi Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease
    Susan J Zieman
    Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Drugs 64:459-70. 2004
  4. ncbi Advances in the prevention and treatment of cardiovascular disease
    Myron L Weisfeldt
    Department of the Medicine, Johns Hopkins Medicine, Baltimore, Maryland, USA
    Health Aff (Millwood) 26:25-37. 2007
  5. ncbi President's page: Cardiovascular care in older adults: the ACC and SGC partnership builds new curriculum
    James T Dove
    J Am Coll Cardiol 51:672-3. 2008

Collaborators

Detail Information

Publications5

  1. ncbi Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension
    Susan J Zieman
    Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Hypertens 25:577-83. 2007
    ..We tested the hypothesis that AGE crosslink breakers enhance endothelial flow-mediated dilation (FMD) in humans and examined the potential mechanisms for this effect...
  2. ncbi Mechanisms, pathophysiology, and therapy of arterial stiffness
    Susan J Zieman
    Department of Medicine, Cardiology Division, National Institute on Aging, Johns Hopkins Medical Institutions, Baltimore, MD, USA
    Arterioscler Thromb Vasc Biol 25:932-43. 2005
    ....
  3. ncbi Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease
    Susan J Zieman
    Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA
    Drugs 64:459-70. 2004
    ..These studies offer promise to reduce the cardiac risk associated with isolated systolic hypertension, diastolic dysfunction and diabetes...
  4. ncbi Advances in the prevention and treatment of cardiovascular disease
    Myron L Weisfeldt
    Department of the Medicine, Johns Hopkins Medicine, Baltimore, Maryland, USA
    Health Aff (Millwood) 26:25-37. 2007
    ....
  5. ncbi President's page: Cardiovascular care in older adults: the ACC and SGC partnership builds new curriculum
    James T Dove
    J Am Coll Cardiol 51:672-3. 2008